Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 0
Capitalization 21,9 M
More Financials
Company
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the... 
Sector
Pharmaceuticals
Calendar
05/11Earnings Release
More about the company
Latest news on GALENA BIOPHARMA INC
04/13 APRIL 14 DEADLINE ALERT : Law Offices of Howard G. Smith Reminds Galena Biopharm..
04/13 GALENA BIOPHARMA INC : DEADLINE TOMORROW: Khang & Khang LLP Announces Securities..
04/12 GALENA BIOPHARMA INC : FRIDAY DEADLINE: Lundin Law PC Announces Securities Class..
04/10 SEC targets fake stock news on financial websites
04/10 SEC targets fake stock news on financial websites
04/10 4-DAY DEADLINE : Khang & Khang LLP Announces Securities Class Action Lawsuit aga..
04/10 GALENA BIOPHARMA INC : 4-DAY DEADLINE: Khang & Khang LLP Announces Securities Cl..
04/10 GALENA BIOPHARMA INC : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Lo..
04/05 GALENA BIOPHARMA INC : DEADLINE APPROACHING: Lundin Law PC Announces Securities ..
04/05 DEADLINE ALERT : GPM Reminds Investors of the April 14 Deadline in the Class Act..
More news
Sector news : Pharmaceuticals - NEC
10:17a Fresenius picks up M&A pace with Akorn, Merck KGaA deals
09:09aDJNOVARTIS : Profit Dented by Investment in New Drugs -- Update
09:04aDJFRESENIUS : Makes Two Acquisitions to Boost Kabi Clinical Unit
09:03aDJBAYER : 1Q 2017 -- Forecast
07:40aDJNOVARTIS : 1Q Net Income Down 17%, Hurt by Drug Failure
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/04$GALE: Galena Biopharma reports interim safety data on NeuVax clinical trial ..
1
04/04$GALE (+13.6% pre) Galena Biopharma Presents Positive Interim Safety Data on ..
1
04/04BRIEF-Galena Biopharma and JGB Newton Ltd entered into waiver that amended se.. 
04/03Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Galena B.. 
03/31Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ga.. 
More tweets
Qtime:12
News from SeekingAlpha
2016 Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 Results - Earnings Cal..
2016 Galena Biopharma beats by $0.02
2016 Notable earnings after Wednesday?s close
2016 RXI PHARMACEUTICALS : Moving On Promising Scar Treatment
2016 Best And Worst Performing Stocks Of 2016
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 3
Average target price 8,00 $
Spread / Average Target 1 268%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephen F. Ghiglieri CEO, CFO & Principal Accounting Officer
Sanford J. Hillsberg Chairman
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
Rudolph Nisi Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC-87.52%22
JOHNSON & JOHNSON6.67%333 142
ROCHE HOLDING LTD.8.21%220 797
PFIZER INC.3.88%200 926
NOVARTIS AG-1.08%195 490
MERCK & CO., INC.5.55%170 359
More Results